Ibritumomab Intravenous and Loxapine Succinate
Determining the interaction of Ibritumomab Intravenous and Loxapine Succinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: loxapine
Brand name: Loxitane, Adasuve
Synonyms: Loxapine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Loxitane
- Ibritumomab Intravenous-Lozol
- Ibritumomab Intravenous-LTA II Kit
- Ibritumomab Intravenous-Lubiprostone
- Ibritumomab Intravenous-Lucemyra
- Ibritumomab Intravenous-Lucentis
- Loxapine Succinate-Ibritumomab Tiuxetan
- Loxapine Succinate-Ibrutinib
- Loxapine Succinate-Ibrutinib Capsules
- Loxapine Succinate-Ibrutinib Tablets
- Loxapine Succinate-Ibu
- Loxapine Succinate-IBU Tablets